Control of hyperphosphatemia in ESRD and dose not promote Aluminum absorption
藥理
It binds phosphorus in the GI tract better than other calcium salts due to its lower solubility and subsequent reduction in calcium or phosphorus absorption
藥動學
Oral absorption is about 30% and depends on vitamin D and parathyroid hormone crosses the placenta, appears in breast milk excreted mainly in feces as unabsorbed calcium with 20% eliminated by the kidneys
禁忌症
Hypercalcemia, calcium-phosphate producrt ﹥60-70 in the setting of uremia is associated with calcification in extraosseous tissues and should be avoided.
懷孕分類
C
哺乳分類
Infant risk cannot be ruled out./Calcium is excreted in breast milk with a significant loss seen during laction.
副作用
constipation or flatulence, hypophosphatemia, hypercalcemia, anorexia, vomiting, thirst
劑量和給藥方法
Adults: 2 tab with each meals; dosage may be increased to bring serum phosphate value to ﹤6 mg/dL
小兒調整劑量
腎功能調整劑量
肝功能調整劑量
安定性
藥袋資訊
臨床用途
高磷酸血症、補充鈣缺乏
主要副作用
噁心、腸胃不適等
泡製方法
儲存方式
請置於 15-30℃ 乾燥處儲存
注意事項
其他說明
藥局 C1、U1<藥包機> | 小庫 M | 藥庫 口B11 | 提醒您,使用時請將夾鏈袋上方封口處剪開使用<2023/12/21>